Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-07-26

Clinical Trial Update: The Effects of the GOLO for Life® Plan With Release Supplement on Glycemic Control and Weight in Overweight and Obese Adults With Prediabetes or Type 2 Diabetes [Phase 2]

View source ↗

Summary

Phase 2 clinical trial updating on the GOLO for Life Plan with Release Supplement for glycemic control and weight in overweight or obese adults with prediabetes…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GOLO for Life Plan with Release Supplement

Snippet

Sponsor: Golo | Conditions: Type 2 Diabetes, Obese | Phase 2 | Status: RECRUITING